Literature DB >> 19945228

Cancer immunoediting and "spontaneous" tumor regression.

Neel Sengupta1, Tammie S MacFie, Thomas T MacDonald, Daniel Pennington, Andrew R Silver.   

Abstract

The combination of host protective and tumor-promoting actions of the immune system throughout tumor development is termed cancer immunoediting. This review briefly summarizes the currently vast evidence supporting the immune system's role in not only protecting against developing cancer, but also sculpting tumor immunogenicity and immune escape. We also briefly summarize the history of immunotherapy and discuss the immunoediting process in the context of spontaneous tumor regression and whether this observation can be utilized in future treatment regimens. Copyright 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19945228     DOI： 10.1016/j.prp.2009.10.001

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN： 0344-0338            Impact factor:   3.250


  18 in total

1.  Spontaneous Tumor Regression in Tasmanian Devils Associated with RASL11A Activation.

Authors:  Mark J Margres; Manuel Ruiz-Aravena; Rodrigo Hamede; Kusum Chawla; Austin H Patton; Matthew F Lawrance; Alexandra K Fraik; Amanda R Stahlke; Brian W Davis; Elaine A Ostrander; Menna E Jones; Hamish McCallum; Patrick J Paddison; Paul A Hohenlohe; David Hockenbery; Andrew Storfer
Journal:  Genetics       Date:  2020-06-18       Impact factor: 4.562

2.  Spontaneous remission in localized diffuse large B-cell lymphoma.

Authors:  László Tamás; Eszter Sári; Gábor Répássy; Péter Szabó; Eniko Bagdi; László Krenács; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2011-06-10       Impact factor: 3.201

3.  Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.

Authors:  Vanessa Deschoolmeester; Marc Baay; Filip Lardon; Patrick Pauwels; Marc Peeters
Journal:  Cancer Microenviron       Date:  2011-05-27

4.  Cancer vaccines.

Authors:  Margaret A Liu
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

5.  Phenylboronic ester-modified polymeric nanoparticles for promoting TRP2 peptide antigen delivery in cancer immunotherapy.

Authors:  Qiyan Wang; Zhipeng Dong; Fangning Lou; Yunxue Yin; Jiahao Zhang; Hanning Wen; Tao Lu; Yue Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

6.  ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.

Authors:  J Ludovic Croxford; Melissa Li Fang Tang; Meng Fei Pan; Caleb Weihao Huang; Neha Kamran; Cindy Meow Ling Phua; Wee Joo Chng; Siok Bian Ng; David H Raulet; Stephan Gasser
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

7.  Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy.

Authors:  Abbas Ali Imani Fooladi; Raheleh Halabian; Mehdi Mahdavi; Mohsen Amin; Hamideh Mahmoodzadeh Hosseini
Journal:  Tumour Biol       Date:  2015-08-06

8.  Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.

Authors:  David Escors
Journal:  New J Sci       Date:  2014-01-05

9.  IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors.

Authors:  Heba A Alshaker; Khalid Z Matalka
Journal:  Cancer Cell Int       Date:  2011-09-23       Impact factor: 5.722

Review 10.  Mechanisms of cyst formation in metastatic lymph nodes of head and neck squamous cell carcinoma.

Authors:  Sepideh Mokhtari
Journal:  Diagn Pathol       Date:  2012-01-16       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.